
Life Science Innovations sp. z o.o. + limited partnership
Trusts, funds and similar financial entities
Overview
Life Science Innovations sp. z o.o. sp. k. (LSI Fund), based in Białystok, incubates disruptive innovations and scales them into global challengers. The fund invests in health care, including preventive medicine and patient technology, in environmental protection, covering clean energy and low- or zero-emission technology, and in biotech and medtech, such as new medical devices, biomaterials and health IT solutions.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 853 days for 2021). 5 of 6 audited by a statutory auditor.
- 202510/06/2026
- 202414/03/2025
- 202314/11/2024
- 202214/11/2024
- 202114/11/2024
- 202029/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Technology investments
- Healthcare innovations
- Environmental protection innovations
- Biotech innovations
- Medtech innovations
Websites
- lsifund.plLSI FundWordPress 3.7DDiviApache
Partners
| Partners | Partner role |
|---|---|
| General partner | |
Adam Cudny age 54 | Limited partner |
| General partner | |
Piotr Jeleński Foundation Fundacja Rodzinna | General partner |
| General partner |
Manner of representation
The general partner acting independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-06-18.
62 1050 1025 1000 0090 3049 4885
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 16, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $29,833$29,833 | MARSZAŁEK MAZOWIECKI | |
| Mar 6, 2018 | Aid for SME access to finance — aid for start-ups | $1.1M$1,071,013 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Idealab Venture Capital sp. z o.o. | $289,216.47 | idealab.pl | ||
| Scanderia Venture sp. z o.o. | $198,970.37 | scanderiaventure.com | ||
| Aligo Alfa sp. z o.o. | $185,657.60 | aligo.vc | ||
| Yoshi Innovation S.A. | $153,586.35 | yoshisa.pl | ||
| Carlson Asi Evig Alfa S.K.A. | $123,331.74 | evigalfa.pl | ||
| Xplorer Fund Asi S.A. | $84,145.82 | xplorerfund.com | ||
| Kogito Ventures S.K.A. | $41,821.28 | kogito-ventures.com | ||
| Smok Ventures S.K.A. | $40,470.43 | smok.vc | ||
| Newberg Ml Spv sp. z o.o. | $30,740.64 | newberg.pl | ||
| FF Venture Capital Alternatywna Spółka Inwestycyjna 2 S.K.A. | $7,803.44 | ffvc.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-10-05 | Name change (Life Science Innovations → Life Science Innovations Spółka Z Ograniczoną Odpowiedzialnością Alternatywna Spółka Inwestycyjna) | |
| 2021-10-05 | PKD change (Removed: 10 codes; Added: 1 code) | |
| 2016-04-26 | Address change (Ul. Wołoska 9, 02-583, Warszawa → Ul. Żurawia 71, 15-540, Białystok) | |
| 2015-02-19 | Address change (Pańska 96/83, 00-837, Warszawa → Ul. Wołoska 9, 02-583, Warszawa) | |
| 2015-02-19 | Name change (Muser → Life Science Innovations) |
FAQ
Last updated: 2026-06-10